Skip to content

The efficacy and safety of Baimai ointment mediated extracorporeal shockwave therapy for postherpetic neuralgia

The efficacy and safety of Baimai ointment mediated extracorporeal shockwave therapy for postherpetic neuralgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092037
Enrollment
Unknown
Registered
2024-11-07
Start date
2023-10-10
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Ultrasound coupling agent mediated group:Basic drugs, paravertebral nerve block, ultrasound coupling agent mediated divergent extracorporeal shock wave therapy
Baimai ointment mediated group:Basic drugs, paraspinal nerve block, and Baimai ointment mediated divergent extracorporeal shock wave therapy

Sponsors

Zhuji Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with postherpetic neuralgia

Exclusion criteria

Exclusion criteria: If combined with other types of acute and chronic painful diseases, severe heart related diseases, coagulation dysfunction, or other interfering factors in the study, VAS score = 3 points, local rash at the treatment site is not healed, ESWT treatment is not suitable, there are mental disorders that cannot cooperate, and those who cannot tolerate the use of drugs in this experiment,

Design outcomes

Primary

MeasureTime frame
visual analogue scale,VAS;

Secondary

MeasureTime frame
hamilton depression scale,HAMD;

Countries

China

Contacts

Public ContactTiejun Jiang

Zhuji Second People's Hospital

tiejunjiang@163.com+86 135 6758 8060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026